ChromaDex(CDXC) - 2023 Q4 - Earnings Call Transcript

Watson's sales were lower due to a challenging comparison in the prior year, which benefited from a catch-up in shipments from earlier quarters as the business gradually recovered post-COVID. Other B2B sales were also down modestly due to the timing of partner sales, which are less predictable. And then as a follow-up with regard to a couple of your partners. Any comments on Watson's and perhaps talk about some of the sell-through trends that you're seeing, and also on Nestle? Perhaps talk about some of the ...